Improving Joint Replacement Materials

Jan 7, 2025 | Medical & Health Sciences

Hip and knee replacements are key for the health and well-being of many people. Unfortunately, the materials used in these procedures are known to wear and corrode once placed within the human body. Dr Stefano Mischler and his team from École Polytechnique Fédérale de Lausanne, together with Professor Dr Brigitte Jolles-Haeberli and her team from Lausanne University Hospital in Switzerland, have conducted exciting new research that advances our understanding of the factors influencing corrosion in the human body. Their work has exciting implications for the future monitoring of implant conditions, particularly valuable in the face of our increasingly ageing population.

Joint Replacement Surgery

Joint replacement surgeries are among the most common elective medical interventions in people over 60 years old. They are performed to help people regain the use of joints, including hips and knees, which have been damaged by degenerative diseases such as osteoarthritis or trauma. Over a million people in the USA undergo hip or knee replacement surgery each year, and with global populations increasingly ageing and increasing high-level recreational sports, this type of surgery is going to become more common around the world.

In this type of surgery, the damaged parts of the joint are replaced with high-quality man-made materials such as metal alloys, including titanium and cobalt-chromium-molybdenum (CoCrMo), primarily used for their strength and resilience.

Joint replacement surgery helps improve people’s quality of life by reducing pain, restoring mobility and, subsequently, their independence. However, the materials used do not last forever in the body, and the average hip replacement lasts approximately 20 years before additional surgery is needed to either repair or replace it.

To improve joint replacement surgery, Dr Stefano Mischler and a team of scientists from École Polytechnique Fédérale de Lausanne and Professor Dr Brigitte Jolles-Haeberli at Lausanne University Hospital set up an important collaboration. Their goal is to revolutionalise understanding of how these materials corrode within the body and to develop materials that last as long as possible, thus reducing the need for additional surgery in people with joint replacements.

Implant Corrosion in the Body

To improve the performance and longevity of these implant materials, it is essential to understand how they deteriorate in the human body. So far, studies investigating these metals have only been performed in laboratory studies using simulated body fluids – which may not accurately represent the conditions in the body. These laboratory studies have shown that the durability of these metals is dependent on a wide range of factors (including those relating to the individual patient). Furthermore, the different factors have only been studied individually. As such, the interactions between various factors as they may occur in the body are not yet fully understood.

To address this knowledge gap, the collaborative team of scientists and clinicians conducted a series of experiments to investigate the corrosion behaviour of implant materials in real human conditions to help predict the lifetime of joint replacement implants.

Professor Dr Jolles-Haeberli, a skilled hip and knee surgeon, extracted synovial fluid (the liquid found in joints that helps them move smoothly) from more than 170 patients during planned elective arthroplasty with patient consent. The pH, colour, and viscosity of the extracted fluid were assessed to help understand how the materials react in different patients. The ability of the synovial fluid to conduct an electrical charge allowed the use of electrochemical techniques to investigate the interaction between the implant materials and the synovial fluid and determine how likely the materials were to corrode and how fast this would happen. The obtained corrosion rates from experiments (proportional to the metal ion release from the implant material into the human body) were compared to the metal ion levels in patients’ urine and found to correspond very well. Therefore, these new experiments could be considered a good marker for the reactivity of a patient toward specific implant material.

Titanium and CoCrMo are often combined in implants. For example, a hip replacement may be made up of a CoCrMo ball attached to a titanium stem. In theory, this combination may increase corrosion in the body if one material is more noble than the other – otherwise known as galvanic corrosion. With the present data, no significant risk of galvanic corrosion in synovial fluid was observed between CoCrMo and Titanium.

Alongside electrochemical corrosion, joint implants are also affected by physical friction and wear and tear caused by movement and mechanical loading. The mechanical wear damages the metal implant, allowing the potentially corrosive synovial fluid to enhance its effect and increase the implant damage rate. The combined effect is known as tribocorrosion and is one of the main causes of joint implant degradation. Dr Mischler is an expert in this phenomenon, and the team combined tribocorrosion models with their electrochemical experiments in synovial fluid to calculate the overall degradation rates of hip replacements. 

Implant Material Corrosion Rates are Patient-specific

A key finding (supporting the team’s previous work) was that corrosion rates of both titanium and CoCrMo implant material vary with the patient in which it is implanted. The team found that the patient’s synovial fluid impacts the lifespan of metals used as implants in multiple ways. Some molecules in the fluid react with the implant and increase the degradation rate, whereas other molecules, such as proteins, can stick to the implant, protecting it from corrosion. They found no risk of galvanic corrosion between the two types of metal as they have very similar electrical properties when submerged in human synovial fluid.

The team also reported that corrosion rates in the study correlated well with levels of metal ions in the patient’s urine. This is a particularly exciting finding as it may be used in the future to understand how long an implant may last in an individual patient, reducing the need for more invasive techniques.

Electrochemical Techniques in Clinical Medicine

The unique collaboration between École Polytechnique Fédérale de Lausanne and Lausanne University Hospital has highlighted the value of electrochemical testing in investigating the longevity of joint replacement implant material. The team’s findings show that metal implant degradation rates are specific to individual patients due to variations in synovial fluid and physical wear factors. This means that the same implant will last for a different amount of time in different patients and emphasises the need for a non-invasive way to measure implant condition. The team’s work demonstrates that the corrosion rates of both titanium and CoCrMo implants in human synovial fluid match closely with the rate at which metal ions are released into the patients. Importantly, this suggests that testing the level of metal ions in patients’ bodies through a simple urine test could be used to monitor the condition and corrosion of their joint replacement implant.

SHARE

DOWNLOAD E-BOOK

REFERENCE

https://doi.org/10.33548/SCIENTIA1118

MEET THE RESEARCHERS

cole Polytechnique Fédérale de Lausanne, Institute of Materials, Tribology and Interface Chemistry, Lausanne, Switzerland


Dr Stefano Mischler

Dr Stefano Mischler obtained his PhD from the Swiss Federal Institute of Technology, where he is now head of the Tribology and Interface Chemistry Unit, where he leads research on surface chemical effects in tribology, biotribology and biocorrosion, tribology in microfabrication processes, and wear protection methods. He has published over 100 peer-reviewed journal articles and several book chapters. In addition to his research, Dr Mischler provides PhD and MSc supervision and teaches both undergraduate and postgraduate courses.

CONTACT

E: stefano.mischler@epfl.ch


Dr Anna Igual Munoz

Dr Anna Igual Munoz received her PhD from the Technical University of Valencia and has subsequently worked at the University of Virginia and École Polytechnique Fédérale de Lausanne, where she is currently a senior scientist responsible for research projects related to electrochemical corrosion and tribology. Dr Igual Munoz sits on the Editorial board of the Journal of Bio- and Tribo-Corrosion and is a reviewer of the Spanish National Foundation and the European Commission. She also supervises and teaches at undergraduate and postgraduate levels and has eight teaching-related publications.

CONTACT

E: anna.igualmunoz@epfl.ch

 

Dr Yueyue Bao

After obtaining an MSc from the University of Science and Technology Beijing, Dr Yueyue Bao was awarded a PhD in the electrochemical behaviour of Ti and CoCrMo alloy in human synovial fluids. Dr Bao’s main research interests are focused on metal and implant materials, tribocorrosion, and electrochemistry. She has presented her work at international conferences. She has received multiple awards and scholarships for her work, including the Miyoshi Outstanding Graduate Student from the University of Science and Technology Beijing and an Academic Merit Scholarship from Hohai University.

CONTACT

E: yueyue.bao@epfl.ch


Professor Dr Brigitte Joles-Haeberli and team, Lausanne University Hospital, Switzerland

Professor Dr Brigitte Jolles-Haeberli founded the Swiss BioMotion Lab (SBML) with Dr Julien Favre in 2014, and continues to lead this laboratory with him. In parallel to her academic activities, she is a senior consultant orthopaedic surgeon in hip and knee surgery at the Hirslanden clinics in Lausanne and the COO of the Department of Musculoskeletal Medicine (DAL) at CHUV. In 2023, she was elected to the renowned French Academy of Surgery in recognition of decades of excellence in orthopaedics as a surgeon, instructor, and researcher.

CONTACT

E: brigitte.jolles-haeberli@chuv.ch

FUNDING

Founds National Suisse

FURTHER READING

Y Bao, A Igual Munoz, B Jolles, S Mischler, Assessment of in-vivo corrosion of Ti and CoCrMo joint implants by electrochemical measurements in human synovial liquids, Electrochimica Acta, 2024, 476, 143708. DOI: https://doi.org/10.1016/j.electacta.2023.143708

 

REPUBLISH OUR ARTICLES

We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence (CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

SUBSCRIBE NOW


Follow Us

MORE ARTICLES YOU MAY LIKE

Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia

Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia

For millions of men, ageing brings with it a set of frustrating and often disruptive urinary symptoms. These symptoms, caused by benign prostatic hyperplasia, or BPH, can affect sleep, confidence, and overall quality of life. Traditionally, treatment follows a familiar path. Patients begin with medications, often for years, and may eventually progress to surgery if symptoms worsen. Yet this pathway is not without its drawbacks. Medications can cause side effects, while surgery carries risks and recovery time. In recent years, a minimally invasive interventional radiology procedure called prostate artery embolisation, or PAE, has begun to challenge this traditional model. At the forefront of this shift is a collaborative research group, led by Dr. Nicholas Brown of the University of Queensland, whose series of P-EASY studies has explored whether PAE could transform how BPH is treated, particularly at earlier stages.

Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach

Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach

Recurrent Aphthous Stomatitis (RAS) is an oral condition characterized by one or several painful mucosal ulcers. RAS affects a large proportion of the population and has a point prevalence of approximately 2–3%, daily. The etiology remains unknown, and there is currently no curative treatment. Most patients experience recurring episodes over time, with each episode typically lasting up to a week. Here, we describe the development of a mucoadhesive patch which, when applied over a RAS ulcer, provides rapid pain relief. The patch is easy for patients to apply when symptoms begin and has the potential to be used as an over-the-counter product. The development of the Mucocort mucoadhesive patch is an example of a Close-to-Market innovation strategy that embraces simplicity within a complex healthcare system. By simplifying the product concept, the team has reduced the number of regulatory steps required before market approval. This MedTech/Pharma innovation model, known as the “4R” framework – Re-purposing, Re-formulation, Re-positioning, and Re-patenting – has guided the program from concept to commercialization. In addition to the biodegradable mucoadhesive patch developed for RAS ulcers, the team is extending the innovation concept to a mucoadhesive gel formulation for the prevention and treatment of chemotherapy-induced mucositis. This gel-based program is being commercialized separately through MucoShield.

The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care

The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care

Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease headon. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.

Ms. Aikaterini Dritsoula | Looking Beyond Snoring: How Hidden Airway Problems Shape Children’s Sleep

Ms. Aikaterini Dritsoula | Looking Beyond Snoring: How Hidden Airway Problems Shape Children’s Sleep

For many parents, a child’s snoring may seem harmless, even endearing. Yet in some cases, it signals something more serious. Obstructive sleep apnoea is a condition in which a child’s breathing is repeatedly disrupted during sleep. These interruptions can affect growth, behaviour, and learning. Children with this condition may toss and turn at night, struggle to concentrate during the day, or show signs of hyperactivity and fatigue. Traditionally, enlarged tonsils and adenoids have been seen as the main culprits. Surgery to remove them has long been considered the standard treatment. However, research led by Consultant ENT Surgeon Ms. Aikaterini Dritsoula of The Leeds Teaching Hospitals NHS Trust invites us to look deeper. Her work suggests that the story is often more complex, especially in very young children.